{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:51:03Z","timestamp":1791600663536,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23PJD074"],"award-info":[{"award-number":["23PJD074"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala Universitet","doi-asserted-by":"publisher","award":["45230040"],"award-info":[{"award-number":["45230040"]}],"id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2023-0241"],"award-info":[{"award-number":["FO2023-0241"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2025-0323-HK-250"],"award-info":[{"award-number":["FO2025-0323-HK-250"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009252","name":"Science for Life Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-03293"],"award-info":[{"award-number":["2021-03293"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019-01422"],"award-info":[{"award-number":["2019-01422"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-04198"],"award-info":[{"award-number":["2022-04198"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-05501"],"award-info":[{"award-number":["2018-05501"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-0550"],"award-info":[{"award-number":["2018-0550"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nbd.2026.107372","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:59:00Z","timestamp":1774972740000},"page":"107372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Spatial lipidomics identifies \u03b1-synuclein-induced lipid changes in an AAV-induced Parkinsonian mouse model"],"prefix":"10.1016","volume":"223","author":[{"given":"Yachao","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per E.","family":"Andren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107372_bb0005","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/mds.27642","article-title":"SMPD1 mutations, activity, and alpha-synuclein accumulation in parkinson\u2019s disease","volume":"34","author":"Alcalay","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107372_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.03.009","article-title":"Metabolic dysfunction in parkinsons disease: bioenergetics, redox homeostasis and central carbon metabolism","volume":"133","author":"Anandhan","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2026.107372_bb0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/jnc.13024","article-title":"Lipid peroxidation is essential for \u03b1-synuclein-induced cell death","volume":"133","author":"Angelova","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2026.107372_bb0020","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1038\/s41418-020-0542-z","article-title":"Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation","volume":"27","author":"Angelova","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2026.107372_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.nbd.2026.107372_bb0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbr.2017.09.023","article-title":"The plasmalogen precursor analog PPI-1011 reduces the development of L-DOPA-induced dyskinesias in de novo MPTP monkeys","volume":"337","author":"Bourque","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2026.107372_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2018.07.012","article-title":"Advances in mass spectrometry imaging enabling observation of localised lipid biochemistry within tissues","volume":"120","author":"Bowman","year":"2019","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.nbd.2026.107372_bb0040","doi-asserted-by":"crossref","first-page":"15610","DOI":"10.1021\/bi061743l","article-title":"Alpha-synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation","volume":"45","author":"Broersen","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2026.107372_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-019-0181-9","article-title":"Effect of the micro-environment on \u03b1-synuclein conversion and implication in seeded conversion assays","volume":"9","author":"Candelise","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107372_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2015.09.002","article-title":"Depressive-like phenotype induced by AAV-mediated overexpression of human \u03b1-synuclein in midbrain dopaminergic neurons","volume":"273","author":"Caudal","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2026.107372_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020173","article-title":"The key role of GM1 ganglioside in parkinson\u2019s disease","volume":"12","author":"Chowdhury","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.nbd.2026.107372_bb0060","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.parkreldis.2015.08.019","article-title":"SMPD1 mutations and parkinson disease","volume":"21","author":"Dagan","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107372_bb0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jmb.2009.09.008","article-title":"Molecular insights into the interaction between alpha-synuclein and docosahexaenoic acid","volume":"394","author":"De Franceschi","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.nbd.2026.107372_bb0070","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex i in human dopaminergic neuronal cultures and parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107372_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"Alpha-synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2026.107372_bb0080","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of parkinson\u2019s disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107372_bb0085","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","article-title":"Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment","volume":"73","author":"Fanning","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2026.107372_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson\u2019s disease: Proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2026.107372_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108132","article-title":"Cell-type- and brain-region-resolved mouse brain lipidome","volume":"32","author":"Fitzner","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2026.107372_bb0100","series-title":"Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2019"},{"key":"10.1016\/j.nbd.2026.107372_bb0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nchembio.1750","article-title":"Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation","volume":"11","author":"Galvagnion","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2026.107372_bb0110","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1212\/WNL.0b013e31828f180e","article-title":"The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for parkinson disease","volume":"80","author":"Gan-Or","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107372_bb0115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41419-025-08030-z","article-title":"The CHCHD2-CHCHD10 protein complex is modulated by mitochondrial dysfunction and alters lipid homeostasis in the mouse brain","volume":"16","author":"Gerlach","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2026.107372_bb0120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2015.03.012","article-title":"Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys","volume":"286","author":"Gregoire","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2026.107372_bb0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JPD-2011-11067","article-title":"Membrane interaction of \u03b1-synuclein in different aggregation states","volume":"1","author":"Grey","year":"2011","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2026.107372_bb0130","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41401-020-0454-y","article-title":"Autophagy-dependent removal of alpha-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against parkinson\u2019s disease","volume":"42","author":"Guo","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.nbd.2026.107372_bb0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-8993(89)90373-9","article-title":"GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study","volume":"484","author":"Hadjiconstantinou","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2026.107372_bb0140","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1038\/s41467-023-41539-5","article-title":"Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents","volume":"14","author":"He","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107372_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/jms.5008","article-title":"Spatial neurolipidomics\u2014MALDI mass spectrometry imaging of lipids in brain pathologies","volume":"59","author":"Jha","year":"2024","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.nbd.2026.107372_bb0150","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/acschemneuro.7b00314","article-title":"Novel trimodal MALDI imaging mass spectrometry (IMS3) at 10 \u03bcm reveals spatial lipid and peptide correlates implicated in a\u03b2 plaque pathology in alzheimers disease","volume":"8","author":"Kaya","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2026.107372_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-023-00558-1","article-title":"Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP parkinsons disease primate model","volume":"9","author":"Kaya","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2026.107372_bb0160","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/jasms.2c00336","article-title":"On-tissue chemical derivatization for comprehensive mapping of brain carboxyl and aldehyde metabolites by MALDI-MS imaging","volume":"34","author":"Kaya","year":"2023","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.nbd.2026.107372_bb0165","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41531-025-01109-6","article-title":"Brain-region-specific lipid dysregulation in L-DOPA-induced dyskinesia in a primate model of parkinson\u2019s disease","volume":"11","author":"Kaya","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2026.107372_bb0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tem.2018.11.003","article-title":"Sphingolipids in the pathogenesis of parkinson\u2019s disease and parkinsonism","volume":"30","author":"Lin","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2026.107372_bb0175","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.1200575109","article-title":"Impaired neurotransmission caused by overexpression of \u03b1-synuclein in nigral dopamine neurons","volume":"109","author":"Lundblad","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2026.107372_bb0180","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/bi061749a","article-title":"GM1 specifically interacts with alpha-synuclein and inhibits fibrillation","volume":"46","author":"Martinez","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2026.107372_bb0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.brainresbull.2022.08.009","article-title":"Decreases of ethanolamine plasmalogen and phosphatidylcholine in erythrocyte are a common phenomenon in alzheimer\u2019s, parkinson\u2019s, and coronary artery diseases","volume":"189","author":"Mawatari","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2026.107372_bb0190","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","article-title":"Understanding dopaminergic cell death pathways in parkinson disease","volume":"90","author":"Michel","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2026.107372_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151020","article-title":"Plasmalogen augmentation reverses striatal dopamine loss in MPTP mice","volume":"11","author":"Miville-Godbout","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2026.107372_bb0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2017.08.020","article-title":"Plasmalogen precursor mitigates striatal dopamine loss in MPTP mice","volume":"1674","author":"Miville-Godbout","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2026.107372_bb0205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2026.107372_bb0210","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170069","article-title":"Sphingolipids: membrane microdomains in brain development, function and neurological diseases","volume":"7","author":"Olsen","year":"2017","journal-title":"Open Biol."},{"key":"10.1016\/j.nbd.2026.107372_bb0215","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1471-4159.2009.06150.x","article-title":"On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft","volume":"110","author":"Park","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2026.107372_bb0220","doi-asserted-by":"crossref","first-page":"34393","DOI":"10.1074\/jbc.M004851200","article-title":"Interaction of human \u03b1-synuclein and parkinson\u2019s disease variants with phospholipids: structural analysis using site-directed mutagenesis","volume":"275","author":"Perrin","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107372_bb0225","doi-asserted-by":"crossref","first-page":"41958","DOI":"10.1074\/jbc.M105022200","article-title":"Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins","volume":"276","author":"Perrin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107372_bb0230","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12035-009-8096-6","article-title":"Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders","volume":"41","author":"Piccinini","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107372_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.nbd.2026.107372_bb0240","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.nbd.2026.107372_bb0245","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.plipres.2010.05.004","article-title":"Alpha-synuclein, lipids and parkinson\u2019s disease","volume":"49","author":"Ruiperez","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.nbd.2026.107372_bb0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-4886(89)90117-9","article-title":"GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism","volume":"105","author":"Schneider","year":"1989","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2026.107372_bb0255","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.256.5058.843","article-title":"Recovery from experimental Parkinsonism in primates with GM1 ganglioside treatment","volume":"256","author":"Schneider","year":"1992","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.nbd.2026.107372_bb0260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jns.2012.10.024","article-title":"A randomized, controlled, delayed start trial of GM1 ganglioside in treated parkinson\u2019s disease patients","volume":"324","author":"Schneider","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2026.107372_bb0265","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2026.107372_bb0270","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3164\/jcbn.18-25","article-title":"Modification of \u03b1-synuclein by lipid peroxidation products derived from polyunsaturated fatty acids promotes toxic oligomerization: its relevance to parkinson disease","volume":"62","author":"Shamoto-Nagai","year":"2018","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.nbd.2026.107372_bb0275","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41592-019-0551-3","article-title":"Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging","volume":"16","author":"Shariatgorji","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2026.107372_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091311","article-title":"The multiple roles of sphingomyelin in parkinson\u2019s disease","volume":"11","author":"Signorelli","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.nbd.2026.107372_bb0285","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/cdd.2011.53","article-title":"A deadly spread: cellular mechanisms of \u03b1-synuclein transfer","volume":"18","author":"Steiner","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2026.107372_bb0290","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson\u2019s disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2026.107372_bb0295","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.1074\/jbc.REV119.007500","article-title":"The role of lipids in alpha-synuclein misfolding and neurotoxicity","volume":"294","author":"Ugalde","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107372_bb0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0079-6123(10)84005-1","article-title":"Viral vector-mediated overexpression of alpha-synuclein as a progressive model of parkinson\u2019s disease","volume":"184","author":"Ulusoy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2026.107372_bb0305","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tins.2003.08.001","article-title":"Alpha-synuclein oligomerization: a role for lipids?","volume":"26","author":"Welch","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2026.107372_bb0310","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s11064-011-0437-y","article-title":"Mice lacking major brain gangliosides develop parkinsonism","volume":"36","author":"Wu","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2026.107372_bb0315","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jnr.23090","article-title":"Deficiency of ganglioside GM1 correlates with parkinson\u2019s disease in mice and humans","volume":"90","author":"Wu","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2026.107372_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010027","article-title":"The role of lipids in parkinson\u2019s disease","volume":"8","author":"Xicoy","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2026.107372_bb0325","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41531-025-01023-x","article-title":"Lipid profiling of parkinson\u2019s disease brain highlights disruption in lysophosphatidylcholines, and triacylglycerol metabolism","volume":"11","author":"Yilmaz","year":"2025","journal-title":"NPJ Parkinsons Dis."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:30:24Z","timestamp":1785151824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":65,"alternative-id":["S0969996126001178"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107372","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial lipidomics identifies \u03b1-synuclein-induced lipid changes in an AAV-induced Parkinsonian mouse model","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107372"}}